BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17916052)

  • 1. In silico prediction of ADMET properties: how far have we come?
    Dearden JC
    Expert Opin Drug Metab Toxicol; 2007 Oct; 3(5):635-9. PubMed ID: 17916052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of ADMET Properties.
    Norinder U; Bergström CA
    ChemMedChem; 2006 Sep; 1(9):920-37. PubMed ID: 16952133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent uses of topological indices in the development of in silico ADMET models.
    Votano JR
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):32-7. PubMed ID: 15679169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving compound quality through in vitro and in silico physicochemical profiling.
    van de Waterbeemd H
    Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction methods and databases within chemoinformatics: emphasis on drugs and drug candidates.
    Jónsdóttir SO; Jørgensen FS; Brunak S
    Bioinformatics; 2005 May; 21(10):2145-60. PubMed ID: 15713739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug molecules.
    Khan MT; Sylte I
    Curr Drug Discov Technol; 2007 Oct; 4(3):141-9. PubMed ID: 17985997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling ADMET.
    Ghosh J; Lawless MS; Waldman M; Gombar V; Fraczkiewicz R
    Methods Mol Biol; 2016; 1425():63-83. PubMed ID: 27311462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico techniques for the identification of bioisosteric replacements for drug design.
    Devereux M; Popelier PL
    Curr Top Med Chem; 2010; 10(6):657-68. PubMed ID: 20337588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictions of the ADMET properties of candidate drug molecules utilizing different QSAR/QSPR modelling approaches.
    Khan MT
    Curr Drug Metab; 2010 May; 11(4):285-95. PubMed ID: 20450477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico ADMET prediction: recent advances, current challenges and future trends.
    Cheng F; Li W; Liu G; Tang Y
    Curr Top Med Chem; 2013; 13(11):1273-89. PubMed ID: 23675935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in computational methods for the prediction of ADMET properties.
    Clark DE; Grootenhuis PD
    Curr Opin Drug Discov Devel; 2002 May; 5(3):382-90. PubMed ID: 12058613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Open access in silico tools to predict the ADMET profiling of drug candidates.
    Kar S; Leszczynski J
    Expert Opin Drug Discov; 2020 Dec; 15(12):1473-1487. PubMed ID: 32735147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From drug target to leads--sketching a physicochemical pathway for lead molecule design in silico.
    Shaikh SA; Jain T; Sandhu G; Latha N; Jayaram B
    Curr Pharm Des; 2007; 13(34):3454-70. PubMed ID: 18220783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehension of drug toxicity: software and databases.
    Toropov AA; Toropova AP; Raska I; Leszczynska D; Leszczynski J
    Comput Biol Med; 2014 Feb; 45():20-5. PubMed ID: 24480159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational toxicology in drug development.
    Muster W; Breidenbach A; Fischer H; Kirchner S; Müller L; Pähler A
    Drug Discov Today; 2008 Apr; 13(7-8):303-10. PubMed ID: 18405842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Informing the Selection of Screening Hit Series with in Silico Absorption, Distribution, Metabolism, Excretion, and Toxicity Profiles.
    Sanders JM; Beshore DC; Culberson JC; Fells JI; Imbriglio JE; Gunaydin H; Haidle AM; Labroli M; Mattioni BE; Sciammetta N; Shipe WD; Sheridan RP; Suen LM; Verras A; Walji A; Joshi EM; Bueters T
    J Med Chem; 2017 Aug; 60(16):6771-6780. PubMed ID: 28418656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery.
    Khakar PS
    Curr Top Med Chem; 2010; 10(1):116-26. PubMed ID: 19929825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADMET in silico modelling: towards prediction paradise?
    van de Waterbeemd H; Gifford E
    Nat Rev Drug Discov; 2003 Mar; 2(3):192-204. PubMed ID: 12612645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial. In silico ADMET predictions in pharmaceutical research.
    Hou T
    Adv Drug Deliv Rev; 2015 Jun; 86():1. PubMed ID: 26138539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.